During the last session, AEON Biopharma Inc (AMEX:AEON)’s traded shares were 3.67 million, with the beta value of the company hitting 0.04. At the end of the trading day, the stock’s price was $0.13, reflecting an intraday loss of -4.41% or -$0.01. The 52-week high for the AEON share is $17.17, that puts it down -13107.69 from that peak though still a striking 23.08% gain since the share price plummeted to a 52-week low of $0.10. The company’s market capitalization is $10.40M, and the average trade volume was 16.84 million shares over the past three months.

AEON Biopharma Inc (AEON) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. AEON has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.18.

AEON Biopharma Inc (AMEX:AEON) trade information

AEON Biopharma Inc (AEON) registered a -4.41% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.41% in intraday trading to $0.13, hitting a weekly high. The stock’s 5-day price performance is -7.14%, and it has moved by 2.36% in 30 days. Based on these gigs, the overall price performance for the year is -98.55%.

AEON Dividends

AEON Biopharma Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.